Ctomy. J Glaucoma 4:7379. 10. Bao P, Kodra A, Tomic-Canic M, Golinko MS, Ehrlich HP, et al. The part of vascular endothelial growth factor in wound healing. J Surg Res 153:347 358. 11. Nissen NN, Polverini PJ, Koch AE, Volin MV, Gamelli RL, et al. Vascular endothelial growth aspect mediates angiogenic activity throughout the proliferative phase of wound healing. Am J Pathol 152:14451452. 12. Li Z, Van Bergen T, Van de Veire S, Van de Vel I, Moreau H, et al. Inhibition of vascular endothelial growth issue reduces scar formation following glaucoma filtration surgery. Invest Ophthalmol Vis Sci 50:52175225. 13. Grewal DS, Jain R, Kumar H, Grewal SPS Evaluation of subconjunctival bevacizumab as an adjunct to trabeculectomy: a pilot study. Ophthalmology 115:21412145. e2142. 14. Jonas JB, Spandau UH, Schlichtenbrede F Intravitreal bevacizumab for filtering surgery. Ophthalmic Investigation 39:121122. 15. Higgins JP, Green S, Collaboration C Cochrane handbook for systematic evaluations of interventions. Wiley On the web Library 5. 16. Moher D, Liberati A, Tetzlaff J, Altman DG Preferred reporting things for systematic evaluations and meta-analyses: the PRISMA statement. Annals of internal medicine 151:264269. 17. Downs SH, Black N The feasibility of making a checklist for the assessment on the methodological excellent both of randomised and nonrandomised studies of health care interventions. Journal of Epidemiology and Neighborhood Well being 52:377384. 18. Reck M, Von Pawel J, Zatloukal PV, Ramlau R, Gorbounova V, et al. All round survival with cisplatingemcitabine and bevacizumab or placebo as firstline therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial. Annals of oncology 21:18041809. 19. Jurkowska-Dudzinska J, Kosior-Jarecka E, Zarnowski T Comparison in the use of 5-fluorouracil and bevacizumab in primary trabeculectomy: outcomes at 1 year. Clin Experiment Ophthalmol 40:e135142. 20. Nilforushan N, Yadgari M, Kish SK, Acetovanillone chemical information Nassiri N Subconjunctival bevacizumab versus mitomycin C adjunctive to trabeculectomy. Am J Ophthalmol 153:352357 e351. 21. Sengupta S, Venkatesh R, Ravindran RD Safety and efficacy of utilizing offlabel bevacizumab versus mitomycin C to stop bleb failure inside a single-site MedChemExpress JI 101 phacotrabeculectomy by a randomized controlled clinical trial. J Glaucoma 21:450459. 22. Simsek T, Cankaya AB, Elgin U Comparison of needle revision with subconjunctival bevacizumab and 5-fluorouracil injection of failed trabeculectomy blebs. J Ocul Pharmacol Ther 28: 542546. 7 A Meta-Analysis 23. Akkan JU, Cilsim S Function of Subconjunctival Bevacizumab as an Adjuvant to Main Trabeculectomy: A Potential Randomized Comparative 1-Year Follow-up Study. J Glaucoma 00:000-000. 24. Kahook MY Bleb morphology and vascularity soon after trabeculectomy with intravitreal ranibizumab: a pilot study. Am J Ophthalmol 150:399403 e391. 25. Chua BE, Nguyen DQ, Qin Q, Ruddle JB, Wells AP, et al. Bleb vascularity following post-trabeculectomy subconjunctival bevacizumab: a pilot study. Clin Experiment Ophthalmol 40:773779. 26. Suh W, Kee C The effect of bevacizumab on the outcome of trabeculectomy with 5-Fluorouracil. J Ocul Pharmacol Ther 29:646651. 27. Freiberg FJ, Matlach J, Grehn F, Karl S, Klink T Postoperative subconjunctival bevacizumab injection as an adjunct to 5-fluorouracil inside the management of scarring after trabeculectomy. Clin Ophthalmol 7:12111217. 28. Hitchings RA, Grierson I Clinico pathological correlation in eyes with failed fistulizing surgery. Trans Oph.Ctomy. J Glaucoma four:7379. ten. Bao P, Kodra A, Tomic-Canic M, Golinko MS, Ehrlich HP, et al. The part of vascular endothelial growth element in wound healing. J Surg Res 153:347 358. 11. Nissen NN, Polverini PJ, Koch AE, Volin MV, Gamelli RL, et al. Vascular endothelial development element mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 152:14451452. 12. Li Z, Van Bergen T, Van de Veire S, Van de Vel I, Moreau H, et al. Inhibition of vascular endothelial development factor reduces scar formation following glaucoma filtration surgery. Invest Ophthalmol Vis Sci 50:52175225. 13. Grewal DS, Jain R, Kumar H, Grewal SPS Evaluation of subconjunctival bevacizumab as an adjunct to trabeculectomy: a pilot study. Ophthalmology 115:21412145. e2142. 14. Jonas JB, Spandau UH, Schlichtenbrede F Intravitreal bevacizumab for filtering surgery. Ophthalmic Analysis 39:121122. 15. Higgins JP, Green S, Collaboration C Cochrane handbook for systematic critiques of interventions. Wiley On the net Library 5. 16. Moher D, Liberati A, Tetzlaff J, Altman DG Preferred reporting products for systematic reviews and meta-analyses: the PRISMA statement. Annals of internal medicine 151:264269. 17. Downs SH, Black N The feasibility of generating a checklist for the assessment with the methodological good quality each of randomised and nonrandomised research of well being care interventions. Journal of Epidemiology and Neighborhood Well being 52:377384. 18. Reck M, Von Pawel J, Zatloukal PV, Ramlau R, Gorbounova V, et al. Overall survival with cisplatingemcitabine and bevacizumab or placebo as firstline therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial. Annals of oncology 21:18041809. 19. Jurkowska-Dudzinska J, Kosior-Jarecka E, Zarnowski T Comparison from the use of 5-fluorouracil and bevacizumab in major trabeculectomy: benefits at 1 year. Clin Experiment Ophthalmol 40:e135142. 20. Nilforushan N, Yadgari M, Kish SK, Nassiri N Subconjunctival bevacizumab versus mitomycin C adjunctive to trabeculectomy. Am J Ophthalmol 153:352357 e351. 21. Sengupta S, Venkatesh R, Ravindran RD Safety and efficacy of using offlabel bevacizumab versus mitomycin C to prevent bleb failure within a single-site phacotrabeculectomy by a randomized controlled clinical trial. J Glaucoma 21:450459. 22. Simsek T, Cankaya AB, Elgin U Comparison of needle revision with subconjunctival bevacizumab and 5-fluorouracil injection of failed trabeculectomy blebs. J Ocul Pharmacol Ther 28: 542546. 7 A Meta-Analysis 23. Akkan JU, Cilsim S Function of Subconjunctival Bevacizumab as an Adjuvant to Primary Trabeculectomy: A Prospective Randomized Comparative 1-Year Follow-up Study. J Glaucoma 00:000-000. 24. Kahook MY Bleb morphology and vascularity immediately after trabeculectomy with intravitreal ranibizumab: a pilot study. Am J Ophthalmol 150:399403 e391. 25. Chua BE, Nguyen DQ, Qin Q, Ruddle JB, Wells AP, et al. Bleb vascularity following post-trabeculectomy subconjunctival bevacizumab: a pilot study. Clin Experiment Ophthalmol 40:773779. 26. Suh W, Kee C The effect of bevacizumab on the outcome of trabeculectomy with 5-Fluorouracil. J Ocul Pharmacol Ther 29:646651. 27. Freiberg FJ, Matlach J, Grehn F, Karl S, Klink T Postoperative subconjunctival bevacizumab injection as an adjunct to 5-fluorouracil within the management of scarring following trabeculectomy. Clin Ophthalmol 7:12111217. 28. Hitchings RA, Grierson I Clinico pathological correlation in eyes with failed fistulizing surgery. Trans Oph.
